Skip to content

LAMP: The development and evaluation of a Lay-facilitated Angina Management Programme

LAMP: The development and evaluation of a Lay-facilitated Angina Management Programme

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN03137160
Enrollment
200
Registered
2005-08-23
Start date
2005-10-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina Circulatory System Angina

Interventions

Participants will be randomised to receive: 1. A 15 minute follow-up appointment with adjunctive written materials and routine medical care 2. Lay-led Angina Management Programme and routine medical c

Sponsors

University of York (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients receiving a diagnosis of angina following symptom-limited exercise treadmill test, thallium scintigraphy or angiography and not, in the judgement of the cardiologist, requiring urgent coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA).

Exclusion criteria

Exclusion criteria: 1. Exercise induced arrhythmias or loss of systolic BP greater than 20 mmHg during exercise stress testing 2. Self-report of rapidly increasing number and duration of attacks of angina 3. A score of 4 on the Canadian Heart Association classification of angina or the New York Heart Association (NYHA) classification of heart failure 4. Myocardial infarction still awaiting cardiac rehabilitation 5. Life-threatening co-morbidities 6. Documented psychiatric problems (other than mild to moderate uni-polar depression or a simple anxiety state) 7. Dementia or confusion

Design outcomes

Primary

MeasureTime frame
Frequency of angina as measured using a patient held angina diary (mean number of angina episodes per week).

Secondary

MeasureTime frame
Secondary outcomes will include differences between baseline and six-month follow-up on: Euroaction SCORE of cardiovascular disease (CVD) risk, scales of the Seattle Angina Questionnaire, anxiety and depression scores on the HADS, increased activity levels as measured by a weeks ambulatory monitoring and self-rated activity level, economic cost utility including service use, cost of the intervention, and the EQ-5D.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026